Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
Open Access
- 1 January 2021
- journal article
- review article
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 51 (8) , 668-680
Abstract
Most important international guidelines recommend the use of CHA(2)DS(2)-VASc and HAS-BLED scores for stroke and bleeding risk assessments in atrial fibrillation (AF) patients, respectively. The 2020 AF guidelines of European Society of Cardiology have revised the definition of "C: congestive heart failure (HF)" component, and now patients with either HF with reduced ejection fraction or preserved ejection fraction should be assigned 1 point. Hypertrophic cardiomyopathy was also included. Besides, the revised "V: vascular diseases" component included both prior myocardial infarction and "angiographically significant coronary artery disease". It is important to understand that the stroke and bleeding risks of AF patients were not static and should be re- assessed regularly. A high HAS-BLED score itself should not be the only reason to withhold or discontinue oral anticoagulants, but remind physicians for the corrections of modifiable bleeding risk factors and more regular follow up. In the future, the AF duration and left atrial function may play an important role for personalized evaluation of individual stroke risk while more studies are necessary.Keywords
This publication has 58 references indexed in Scilit:
- The prognostic role of the adiponectin levels in atrial fibrillationEuropean Journal of Clinical Investigation, 2012
- Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?JACC, 2012
- High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillationJournal of Thrombosis and Haemostasis, 2012
- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial FibrillationCirculation, 2012
- Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation PatientsJACC, 2011
- Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial FibrillationJACC, 2011
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyBMJ, 2011
- Left Atrial Appendage Dimensions Predict the Risk of Stroke/TIA in Patients With Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2011
- C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillationInternational Journal of Cardiology, 2010
- Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial FibrillationCirculation, 2003